Eledon Pharmaceuticals, Inc. / Fundamentals

    Income statement

    Net revenue
    €165.42K
    Cost of goods sold
    €0.00
    Gross profit
    €165.42K
    SG&A expenses
    €16.93M
    R&D expenses
    €58.81M
    EBITDA
    -€75.59M
    D&A
    €143.88K
    EBIT
    -€75.57M
    Interest expenses
    €0.00
    EBT
    €12.99M
    Tax expenses
    -€371.33K
    Net income
    €12.62M

    Cash flow statement

    Net deferred tax
    €371.33K
    Non-cash items
    -€53.89M
    Changes in working capital
    -€4.26M
    Operating cash flow
    -€55.59M
    Capex
    €0.00
    Other investing cash flow
    €0.00
    Net investing cash flow
    -€35.61M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €73.43M
    Debt repayment
    €0.00
    Other financing cash flow
    €284.31K
    Net financing cash flow
    €73.72M
    Foreign exchange effects
    €0.00
    Net change in cash
    -€17.49M
    Cash at end of period
    €4.95M
    Free cash flow
    -€55.59M

    Balance sheet

    Cash and cash equivalents
    €4.95M
    Cash and short-term investments
    €92.68M
    Total receivables
    €607.39K
    Inventory
    €0.00
    Other current assets
    €2.70M
    Total current assets
    €95.98M
    Property, plant & equipment
    €665.98K
    Goodwill
    €0.00
    Intangible assets
    €27.90M
    Long-term investments
    €0.00
    Other non-current assets
    €298.10K
    Total non-current assets
    €28.87M
    Total assets
    €124.85M
    Accounts payable
    €5.02M
    Short-term debt
    €289.48K
    Other current liabilities
    €6.51M
    Total current liabilities
    €11.82M
    Long-term debt
    €402.34K
    Deferred tax liabilities
    €1.88M
    Other non-current liabilities
    €67.38M
    Total non-current liabilities
    €69.66M
    Total liabilities
    €81.48M
    Common stock
    €51.69K
    Retained earnings
    -€321.61M
    Other equity
    -€41.35K
    Total equity
    €43.37M
    Total liabilities and shareholders' equity
    €124.85M

    Company information

    Market capitalization
    €137.40M
    Employees
    31
    Enterprise Value
    €172.03M

    Company ratios

    Gross margin
    100.0% Much better than peer group: -224.6%
    EBITDA margin
    -45,695.8% Much worse than peer group: -4,399.8%
    EBIT margin
    -45,682.8% Much worse than peer group: -4,424.5%
    EBT margin
    7,851.0% Much better than peer group: -4,255.8%
    Net margin
    7,626.6% Much better than peer group: -4,244.3%
    ROE
    29.1% Much better than peer group: -44.6%
    ROA
    10.1% Much better than peer group: -45.9%
    Asset turnover
    0.1% Worse than peer group: 9.0%
    FCF margin
    -33,608.9% Much worse than peer group: -3,505.9%
    FCF yield
    -40.5%
    Efficiency ratio
    45,795.8%
    Net sales per employee
    €5.34K
    Net income per employee
    €406.96K

    Notifications